Company Overview - David Medical's closing price on July 4 was 12.77 yuan, down 1.01%, with a rolling PE ratio of 88.15 times and a total market value of 3.678 billion yuan [1] - The company ranks 105th in the medical device industry, which has an average PE ratio of 51.05 times and a median of 36.62 times [1] Financial Performance - For Q1 2025, the company reported revenue of 121 million yuan, a year-on-year decrease of 22.00%, and a net profit of 22.57 million yuan, down 40.78% year-on-year [2] - The sales gross margin was reported at 57.13% [2] Shareholding Structure - As of the Q1 2025 report, there are 2 institutional investors holding shares in David Medical, including 1 QFII and 1 insurance company, with a total holding of 1.2529 million shares valued at 1.5 million yuan [1] Product Portfolio - David Medical specializes in obstetric and pediatric care equipment, minimally invasive surgical instruments, and emergency ICU products, including incubators, radiant warmers, jaundice treatment devices, and various monitoring and therapeutic equipment [1] Industry Recognition - The company has been recognized as a "Manufacturing Industry Single Champion Cultivation Enterprise" by the Ministry of Industry and Information Technology and has received multiple honors, including "Famous Brand in Zhejiang Province" and "AAA Credit Rating Enterprise" [1]
戴维医疗收盘下跌1.01%,滚动市盈率88.15倍,总市值36.78亿元